Daré Bioscience’s $22 Million Non-Dilutive Strategic Royalty Financing

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Daré Bioscience, Inc. on the transaction, and Gibson, Dunn & Crutcher advised XOMA (US) LLC.Daré Bioscience, Inc. (NASDAQ:…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here